{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:34:16Z","timestamp":1765143256085,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ajem.2017.03.040","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T03:02:13Z","timestamp":1490238133000},"page":"1207.e3-1207.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Review of potential drug interaction between Oseltamivir and Warfarin and why it is important for emergency medicine physicians"],"prefix":"10.1016","volume":"35","author":[{"given":"Siddharth P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinner M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogin","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvir Singh","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajem.2017.03.040_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11595860-000000000-00000","article-title":"Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review","volume":"32","author":"Lee","year":"2012","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.ajem.2017.03.040_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0022-3859.57411","article-title":"Oseltamivir","volume":"55","author":"Tullu","year":"2009","journal-title":"J Postgrad Med"},{"issue":"6","key":"10.1016\/j.ajem.2017.03.040_bb0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2125.2010.03780.x","article-title":"Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients","volume":"70","author":"Davies","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ajem.2017.03.040_bb0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1177\/1060028013500940","article-title":"Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries","volume":"47","author":"Mosholder","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ajem.2017.03.040_bb0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.ajem.2017.03.040_bb0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","article-title":"Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802","volume":"37","author":"He","year":"1999","journal-title":"Clin Pharmacokinet"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717302061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717302061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:37:14Z","timestamp":1760024234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675717302061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0735675717302061"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2017.03.040","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of potential drug interaction between Oseltamivir and Warfarin and why it is important for emergency medicine physicians","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2017.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}